PMID: 517883Dec 1, 1979Paper

Complete remissions in metastatic breast cancer treated with combination drug therapy

Annals of Internal Medicine
S S LeghaE J Freireich

Abstract

One hundred sixteen patients with metastatic breast cancer who achieved complete remission with combination chemotherapy were analyzed to ascertain the factors that affect the duration of complete remission and the patterns of relapse. The median duration of complete remission was 17 months. Disease recurred in 81 patients (70%) at periods ranging from 3 to 44 months after achievement of complete remission. The duration of complete remission was inversely related to the bulk of metastatic tumor. Twenty-three patients treated with combined oophorectomy and chemotherapy experienced the longest remissions (median duration of 33 months); only eight (35%) of them have relapsed. Seventy-six percent of the relapses occurred in previously known sites of tumor involvement; most of the remainder involved the brain. The short duration of complete remissions and tendency to relapse in sites of initial involvement suggest that patients with metastatic breast cancer who achieved complete remission with combination chemotherapy still had substantial residual tumor. Consolidation treatments, using hormonal therapy and non-cross-resistant chemotherapy along with irradiation to initial sites of metastases, whould be investigated to ascertain the...Continue Reading

Citations

Jan 1, 1981·Cancer Chemotherapy and Pharmacology·M H Cohen
Jan 1, 1993·Breast Cancer Research and Treatment·D V Schapira
Apr 1, 1987·Klinische Wochenschrift·H E WanderD Emrich
Jan 1, 1983·Breast Cancer Research and Treatment·J H Goldie
Jan 1, 1982·Breast Cancer Research and Treatment·P S Stewart
Jan 1, 1984·Breast Cancer Research and Treatment·M E Lippman
Nov 20, 2004·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Yutaka OkawaTadashi Kobayashi
Oct 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E TomiakR D Rubens
Sep 3, 1999·Breast Cancer Research and Treatment·L PusztaiG N Hortobagyi
Oct 29, 2005·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Rafael MolinaPetra Stieber
Sep 1, 1995·Breast Cancer Research and Treatment·R V IaffaioliF Caponigro
Nov 7, 1998·Cancer Treatment Reviews·Z U RahmanR Champlin
Sep 1, 1982·The Journal of Computed Tomography·M L ShiS Handel
Jun 1, 1987·European Journal of Cancer & Clinical Oncology·G Schwartsmann, H M Pinedo
Mar 1, 1985·European Journal of Cancer & Clinical Oncology·G P Bodey
Jun 1, 1991·Blood Reviews·G Spitzer
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M Clavel, G Catimel
Feb 10, 2007·Expert Review of Anticancer Therapy·Joseph G Sinkovics
Jan 1, 1988·Seminars in Surgical Oncology·J H Ward, H J Eyre
May 1, 1997·Cancer Control : Journal of the Moffitt Cancer Center·G N Hortobagyi
Aug 1, 1995·Journal of Surgical Oncology·W L Donegan
Apr 1, 1983·Journal of Surgical Oncology·P SchickK L Senter
Jan 15, 1983·British Medical Journal
Jan 7, 2017·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Giulia GalliSerena Di Cosimo
Dec 10, 2016·Cancer Metastasis Reviews·Bora Lim, Gabriel N Hortobagyi
Jan 18, 1988·The Medical Journal of Australia·G P Canellos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.